Is Sensus Healthcare Stock a Good Investment?
Sensus Healthcare Investment Advice | SRTS |
- Examine Sensus Healthcare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Sensus Healthcare's leadership team and their track record. Good management can help Sensus Healthcare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Sensus Healthcare's business and its evolving consumer preferences.
- Compare Sensus Healthcare's performance and market position to its competitors. Analyze how Sensus Healthcare is positioned in terms of product offerings, innovation, and market share.
- Check if Sensus Healthcare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Sensus Healthcare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sensus Healthcare stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sensus Healthcare is a good investment.
Sell | Buy |
Hold
Market Performance | Good | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Sensus Healthcare Stock
Researching Sensus Healthcare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 19.0% of the company outstanding shares are owned by corporate insiders. The book value of Sensus Healthcare was at this time reported as 1.57. The company had not issued any dividends in recent years.
To determine if Sensus Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sensus Healthcare's research are outlined below:
| Sensus Healthcare appears to be risky and price may revert if volatility continues | |
| Sensus Healthcare is unlikely to experience financial distress in the next 2 years | |
| Sensus Healthcare currently holds about 33.7 M in cash with (2.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Sensus Healthcare has a strong financial position based on the latest SEC filings | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Santander Markets At Least a Dozen SRTs in Move to Boost Profits |
Sensus Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sensus Healthcare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sensus Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Sensus Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sensus Healthcare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-11-03 | 2016-09-30 | -0.01 | -0.0023 | 0.0077 | 77 | ||
2019-11-06 | 2019-09-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2018-08-02 | 2018-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2017-11-02 | 2017-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2022-11-03 | 2022-09-30 | 0.13 | 0.11 | -0.02 | 15 | ||
2020-08-06 | 2020-06-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2019-02-14 | 2018-12-31 | -0.01 | 0.01 | 0.02 | 200 | ||
2018-05-03 | 2018-03-31 | -0.06 | -0.08 | -0.02 | 33 |
Know Sensus Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sensus Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sensus Healthcare backward and forwards among themselves. Sensus Healthcare's institutional investor refers to the entity that pools money to purchase Sensus Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-09-30 | 76.3 K | Arrowstreet Capital Limited Partnership | 2024-06-30 | 76.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 72.5 K | Blackrock Inc | 2024-06-30 | 64.9 K | State Street Corp | 2024-06-30 | 57.2 K | Northern Trust Corp | 2024-09-30 | 53 K | Millennium Management Llc | 2024-06-30 | 49.9 K | Susquehanna International Group, Llp | 2024-06-30 | 47.1 K | Man Group Plc | 2024-09-30 | 44.3 K | Vanguard Group Inc | 2024-09-30 | 779.1 K | Renaissance Technologies Corp | 2024-09-30 | 409.3 K |
Sensus Healthcare's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 145.71 M.Market Cap |
|
Sensus Healthcare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Determining Sensus Healthcare's profitability involves analyzing its financial statements and using various financial metrics to determine if Sensus Healthcare is a good buy. For example, gross profit margin measures Sensus Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sensus Healthcare's profitability and make more informed investment decisions.
Sensus Healthcare's Earnings Breakdown by Geography
Please note, the imprecision that can be found in Sensus Healthcare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sensus Healthcare. Check Sensus Healthcare's Beneish M Score to see the likelihood of Sensus Healthcare's management manipulating its earnings.
Evaluate Sensus Healthcare's management efficiency
Sensus Healthcare has return on total asset (ROA) of 0.097 % which means that it generated a profit of $0.097 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1344 %, meaning that it created $0.1344 on every $100 dollars invested by stockholders. Sensus Healthcare's management efficiency ratios could be used to measure how well Sensus Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sensus Healthcare's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop (0.01) in 2024. At this time, Sensus Healthcare's Net Tangible Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 844.2 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.00 | 3.15 | |
| Tangible Book Value Per Share | 3.00 | 3.15 | |
| Enterprise Value Over EBITDA | 533.56 | 602.42 | |
| Price Book Value Ratio | 0.79 | 0.75 | |
| Enterprise Value Multiple | 533.56 | 602.42 | |
| Price Fair Value | 0.79 | 0.75 | |
| Enterprise Value | 16 M | 15.2 M |
Understanding the operational decisions made by Sensus Healthcare management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 1.045 |
Basic technical analysis of Sensus Stock
As of the 25th of November, Sensus Healthcare has the Semi Deviation of 3.14, coefficient of variation of 743.17, and Risk Adjusted Performance of 0.111. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sensus Healthcare, as well as the relationship between them. Please validate Sensus Healthcare variance and potential upside to decide if Sensus Healthcare is priced more or less accurately, providing market reflects its prevalent price of 8.89 per share. Given that Sensus Healthcare has jensen alpha of 0.3002, we advise you to double-check Sensus Healthcare's current market performance to make sure the company can sustain itself at a future point.Sensus Healthcare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sensus Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sensus Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sensus Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sensus Healthcare's Outstanding Corporate Bonds
Sensus Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sensus Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sensus bonds can be classified according to their maturity, which is the date when Sensus Healthcare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| SENMED 2927 01 NOV 51 Corp BondUS81728XAA63 | View | |
| ST 5875 01 SEP 30 Corp BondUS81725WAL72 | View | |
| US81725WAK99 Corp BondUS81725WAK99 | View | |
| SENIOR HSG PPTYS Corp BondUS81721MAM10 | View | |
| SENSATA TECHNOLOGIES INC Corp BondUS81728UAB08 | View | |
| Sensata Technologies 4375 Corp BondUS81728UAA25 | View |
Understand Sensus Healthcare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Sensus Healthcare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.111 | |||
| Market Risk Adjusted Performance | 0.3542 | |||
| Mean Deviation | 2.63 | |||
| Semi Deviation | 3.14 | |||
| Downside Deviation | 3.49 | |||
| Coefficient Of Variation | 743.17 | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.33 | |||
| Information Ratio | 0.0973 | |||
| Jensen Alpha | 0.3002 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.098 | |||
| Treynor Ratio | 0.3442 | |||
| Maximum Drawdown | 14.56 | |||
| Value At Risk | (3.97) | |||
| Potential Upside | 6.23 | |||
| Downside Variance | 12.16 | |||
| Semi Variance | 9.84 | |||
| Expected Short fall | (3.10) | |||
| Skewness | (0.38) | |||
| Kurtosis | 2.45 |
| Risk Adjusted Performance | 0.111 | |||
| Market Risk Adjusted Performance | 0.3542 | |||
| Mean Deviation | 2.63 | |||
| Semi Deviation | 3.14 | |||
| Downside Deviation | 3.49 | |||
| Coefficient Of Variation | 743.17 | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.33 | |||
| Information Ratio | 0.0973 | |||
| Jensen Alpha | 0.3002 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.098 | |||
| Treynor Ratio | 0.3442 | |||
| Maximum Drawdown | 14.56 | |||
| Value At Risk | (3.97) | |||
| Potential Upside | 6.23 | |||
| Downside Variance | 12.16 | |||
| Semi Variance | 9.84 | |||
| Expected Short fall | (3.10) | |||
| Skewness | (0.38) | |||
| Kurtosis | 2.45 |
Consider Sensus Healthcare's intraday indicators
Sensus Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sensus Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sensus Healthcare Corporate Filings
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 13th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 23rd of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 17th of July 2024 Other Reports | ViewVerify |
Sensus Stock media impact
Far too much social signal, news, headlines, and media speculation about Sensus Healthcare that are available to investors today. That information is available publicly through Sensus media outlets and privately through word of mouth or via Sensus internal channels. However, regardless of the origin, that massive amount of Sensus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sensus Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sensus Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sensus Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sensus Healthcare alpha.
Sensus Healthcare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Sensus Healthcare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sensus Healthcare Corporate Management
| Magdalena Martinez | Chief Officer | Profile | |
| Nicolas Soro | Chief Officer | Profile | |
| Emiliano Sosa | Chief Officer | Profile | |
| Benson Suen | VP Sales | Profile | |
| Mark Nestor | Medical Board | Profile |
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.